Immunopathology of atherosclerosis and related diseases: focus on molecular biology

EE Bezsonov, IA Sobenin, AN Orekhov - International journal of molecular …, 2021 - mdpi.com
Chronic inflammation is a pathogenic mechanism of many diseases causing up to 80% of
morbidity and mortality in developed countries. Despite many discoveries made in the field …

Anti-inflammatory therapeutic approaches to reduce acute atherosclerotic complications

I Kanzler, EA Liehn, RR Koenen… - Current pharmaceutical …, 2012 - ingentaconnect.com
Cardiovascular diseases, including atherosclerosis and the dreaded complication
myocardial infarction, represent the major cause of death in western countries. It is now …

Circulating biomarkers determining inflammation in atherosclerosis progression

G Siasos, V Tsigkou, E Oikonomou… - Current Medicinal …, 2015 - ingentaconnect.com
Atherosclerosis is the main underlying pathology of cardiovascular disease and is
precipitated by various hereditary and non-hereditary risk factors. Inflammation is …

[HTML][HTML] Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review

P Adegbola, I Aderibigbe, W Hammed… - American journal of …, 2017 - ncbi.nlm.nih.gov
Cardiovascular disease is a compound name for clusters of disorders afflicting the heart and
blood vessels; it is assuming an increasing role as a major cause of morbidity and mortality …

Inflammation as a precursor of atherothrombosis, diabetes and early vascular aging

E Barbu, MR Popescu, AC Popescu… - International Journal of …, 2022 - mdpi.com
Vascular disease was for a long time considered a disease of the old age, but it is becoming
increasingly clear that a cumulus of factors can cause early vascular aging (EVA) …

The role and predictive value of cytokines in atherosclerosis and coronary artery disease

D Tousoulis, EK Economou… - Current medicinal …, 2015 - ingentaconnect.com
Atherosclerosis is currently regarded as a chronic inflammatory disease that is mediated by
several types of cells and molecules. Emphasis has been placed on the role of cytokines …

Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective

V Mallika, B Goswami, M Rajappa - Angiology, 2007 - journals.sagepub.com
Atherosclerosis is the root cause of the biggest killer of the 21st century. Mechanisms
contributing to atherogenesis are multiple and complex. A number of theories—including the …

[PDF][PDF] Inflammatory biomarkers of coronary heart disease

H Li, K Sun, R Zhao, J Hu, Z Hao, F Wang… - … Biosci (Schol Ed), 2018 - article.imrpress.com
Introduction 3. Characteristics of atherosclerosis 4. Inflammation cascade involved the
development of atherosclerosis and CHD 5. Predictive inflammatory biomarkers in CHD 5.1 …

The effects of pro-inflammatory and anti-inflammatory agents for the suppression of intimal hyperplasia: an evidence-based review

R Che Man, N Sulaiman, MF Ishak… - International journal of …, 2020 - mdpi.com
Anti-atherogenic therapy is crucial in halting the progression of inflammation-induced intimal
hyperplasia. The aim of this concise review was to methodically assess the recent findings of …

Natural products in regression and slowing of progression of atherosclerosis

K Prasad - Current Pharmaceutical Biotechnology, 2010 - ingentaconnect.com
Many natural products, including vitamin E, garlic, purpurogallin, flaxseed and its
components [secoisolariciresinol diglucoside (SDG) and flax lignan complex (FLC)] and …